Compare ResMed Inc. (RMD) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs United States Oil ETF — how do they compare? ResMed Inc. trades at $228.88 (market cap $31.89B), while United States Oil ETF trades at $147.77 (market cap $1.90B). The key difference: ResMed Inc. is far larger — about 16.8× United States Oil ETF's market cap, and ResMed Inc. pays a 1.16% dividend while United States Oil ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and United States Oil ETF for 21 Days on average.
| RMD | USO | |
|---|---|---|
Market Cap | $31.89B | $1.90B |
Volume | 618,314 | 5,932,922 |
Sector | Health | — |
52-Week High | $277.88 | $161.86 |
52-Week Low | $182.82 | $66.17 |
Typical Hold Time | 51 Days | 21 Days |
Enterprise Value | $31.24B | — |
Dividend Yield | 1.16% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $228.37, up 1.06% today, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15B in 2025, with a robust net income margin of 26.94%. Recent news highlights management's presentation at the Morgan Stanley Healthcare Conference and an upcoming Q1 2027 earnings report.
The outlook is positive, supported by earnings growth targets of 12-14% and a consensus price target of $242.70. Key risks include competitive pressures and ongoing legal investigations. Institutional buying activity and analyst upgrades reflect confidence, but investors should monitor execution against growth targets and any developments from the legal probe.
USO is trading at $147.835, up 2.73% with a bullish technical signal from moving averages. The stock shows neutral oscillators but faces mixed oil market conditions with Middle East tensions and G-7 reserve releases creating volatility. Recent news highlights supply disruptions and geopolitical risks affecting crude prices.
The outlook remains cautious with geopolitical risks and supply uncertainties balancing against potential price support from production constraints. Investment opportunities exist if supply disruptions persist, but risks include regulatory pressures and volatile oil markets that could impact shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
